Pharvaris N.V. Ordinary Shares (PHVS) News

Latest headlines that mention PHVS, newest first · each headline opens the original publisher

PHVS quote

Last price: $31.12
Day change: -1.77%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

PHVS headlines

last 30 days

Investing.com 1h ago

Pharvaris HAE drug shows faster symptom relief in Lancet study

General T3PHVS

Seeking Alpha News 23d ago

Pharvaris N.V. (PHVS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2PHVS

Investing.com 24d ago

Cantor Fitzgerald reiterates Pharvaris stock rating after trial data

General T3PHVS

Seeking Alpha News 28d ago

Pharvaris N.V. (PHVS) Discusses Topline Results of Chapter-3 Phase III Study on Deucrictibant for Prophylactic Treatment of Hereditary Angioedema - Slideshow

General T2PHVS

Investing.com 28d ago

Pharvaris at Cantor Fitzgerald conference: oral HAE push gains momentum

General T3PHVS

Investing.com 28d ago

Pharvaris at Wells Fargo conference: oral HAE drug gains ground

General T3PHVS

Seeking Alpha News 29d ago

Pharvaris: 'Strong Buy' Based On Deucrictibant PDUFA And Prophylaxis Trial Win

General T2PHVS

PHVS news alerts

Get an alert by email or push when a new headline mentions PHVS.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.